ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer-Reference-Cited by-同舟云学术

ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer

Published:2005-05 Issue: Volume:16 Page:i7-i9
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Pestalozzi B.C.,Luporsi-Gely E.,Jost L.M.,Bergh J.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/16/suppl_1/i7/966682/mdi825.pdf

Reference17 articles.

1. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up;Bonadonna;N Engl J Med,1995

2. Polychemotherapy for early breast cancer: an overview of the randomised trials;Lancet,1998

3. Tamoxifen for early breast cancer: an overview of the randomised trials;Lancet,1998

4. Meeting highlights: International Consensus Panel on the Primary Treatment of Early Breast Cancer;Goldhirsch;Ninth International Conference on Primary Therapy of Early Breast Cancer. J Clin Oncol,2003

5. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer;Fisher;J Clin Oncol,1998

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-surgery statin use contributes to favorable outcomes in patients with early breast cancer;Cancer Epidemiology;2024-06

2. CD105 expression in cancer-associated fibroblasts: a biomarker for bone metastasis in early invasive ductal breast cancer patients;Frontiers in Cell and Developmental Biology;2023-08-31

3. Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) – Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities;Geburtshilfe und Frauenheilkunde;2022-02

4. Current immunoassay methods and their applications to clinically used biomarkers of breast cancer;Clinical Biochemistry;2020-04

5. A long-term retrospective comparative study of the oncological outcomes of 598 very young (≤35 years) and young (36–45 years) breast cancer patients;European Journal of Surgical Oncology;2019-11